We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.34%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WIRE
1351
DELISTED
Encore Wire Corp
WIRE
$3.73M 0.01%
+27,117
New +$3.75M
CHEF icon
1352
Chefs' Warehouse
CHEF
$3.9B
$3.73M 0.01%
112,060
-345,124
-75% -$12M
USB icon
1353
PUT
US Bancorp
USB
$98.9B
$3.72M 0.01%
85,200
+6,800
+9% +$291K
LHC.WS
1354
CALL
DELISTED
Leo Holdings Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
LHC.WS
$3.71M 0.01%
367,949
LILAK icon
1355
Liberty Latin America Class C
LILAK
$1.55B
$3.71M 0.01%
537,215
-158,219
-23% -$1.08M
BSAQ
1356
DELISTED
Black Spade Acquisition Co
BSAQ
$3.7M 0.01%
370,374
TZPSW
1357
CALL
DELISTED
TZP Strategies Acquisition Corp. Warrant
TZPSW
$3.7M 0.01%
366,658
DISAW
1358
CALL
DELISTED
Disruptive Acquisition Corporation I Warrant
DISAW
$3.7M 0.01%
366,662
TGVC
1359
DELISTED
TG Venture Acquisition Corp. Class A Common Stock
TGVC
$3.69M 0.01%
363,895
DHR icon
1360
PUT
Danaher
DHR
$138B
$3.69M 0.01%
+15,679
New +$3.63M
CTRE icon
1361
CareTrust REIT
CTRE
$10.1B
$3.68M 0.01%
+198,207
New +$3.7M
MATX icon
1362
Matsons
MATX
$6.22B
$3.68M 0.01%
58,848
-6,276
-10% -$415K
BNNRW
1363
CALL
DELISTED
Banner Acquisition Corp. Warrants
BNNRW
$3.67M 0.01%
364,167
SPNS
1364
DELISTED
Sapiens International
SPNS
$3.67M 0.01%
198,485
-62,552
-24% -$1.18M
CCAIW
1365
CALL
DELISTED
Cascadia Acquisition Corp. Warrant
CCAIW
$3.66M 0.01%
361,957
NBIX icon
1366
Neurocrine Biosciences
NBIX
$17.7B
$3.64M 0.01%
+30,446
New +$3.57M
CPTK
1367
CALL
DELISTED
Crown PropTech Acquisitions
CPTK
$3.64M 0.01%
359,593
ADERW
1368
CALL
DELISTED
26 Capital Acquisition Corp Warrant
ADERW
$3.63M 0.01%
358,000
IVCAW
1369
CALL
DELISTED
Investcorp AI Acquisition Corp. Warrant
IVCAW
$3.62M 0.01%
349,999
FDX icon
1370
CALL
FedEx
FDX
$73.5B
$3.62M 0.01%
20,900
-45,900
-69% -$7.63M
SYY icon
1371
CALL
Sysco
SYY
$40.2B
$3.62M 0.01%
47,300
-73,100
-61% -$5.91M
COKE icon
1372
Coca-Cola Consolidated
COKE
$12.4B
$3.61M 0.01%
70,480
-44,420
-39% -$2.12M
TLGY
1373
DELISTED
TLGY Acquisition Corporation Class A Ordinary Share
TLGY
$3.61M 0.01%
352,479
PLD icon
1374
CALL
Prologis
PLD
$137B
$3.61M 0.01%
+32,000
New +$3.55M
PACK icon
1375
Ranpak Holdings
PACK
$572M
$3.61M 0.01%
625,076
-683,833
-52% -$3.27M

Similar funds

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.